G01N 2333/96405
In general
Official title: in general
G01N2333/96405 (In general) appears on 79 US grants and 158 published applications in this corpus.
Search patents in G01N- Granted patents
- 79
- Published applications
- 158
- Assignees
- 110
- Inventors
- 405
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 4 |
| 2010 | 1 | 6 |
| 2011 | 1 | 5 |
| 2012 | 3 | 7 |
| 2013 | 1 | 2 |
| 2014 | 4 | 4 |
| 2015 | 4 | 9 |
| 2016 | 1 | 7 |
| 2017 | 2 | 6 |
| 2018 | 5 | 9 |
| 2019 | 5 | 11 |
| 2020 | 5 | 11 |
| 2021 | 7 | 7 |
| 2022 | 6 | 12 |
| 2023 | 9 | 9 |
| 2024 | 6 | 21 |
| 2025 | 6 | 14 |
| 2026 | 4 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for producing an exdotoxin measuring agent29 Sep 2026US 12,748,115 B2Seikagaku Corporation
- Methods of characterizing and purifying VEGF receptor fusion protein25 Aug 2026US 12,715,905 B2Regeneron Pharmaceuticals, Inc.
- Method for predicting formation of thrombus or risk of thrombus formation in medical device performing blood circulation by pump31 Mar 2026US 12,590,962 B2Terumo Kabushiki Kaisha
- Ivaltinostat combination therapy for treating pancreatic cancer17 Feb 2026US 12,553,903 B2CG Pharmaceuticals, Inc
- Capture antibody and detection antibody binding MMP9 protein30 Dec 2025US 12,510,542 B1MİMARK Diagnostics, S.L.
- Methods and compositions for diangosis of ectopic pregnancy10 Sep 2026US 2026/0266840 A1The Trustees of the University of Pennsylvania
- Method and device for predicting significant gastric aspiration and lung transplant outcome30 Jul 2026US 2026/0219272 A1University Health Network
- Method for producing recombinant horseshoe crab factor, endotoxin assay agent, and method for producing endotoxin assay agent23 Jul 2026US 2026/0209738 A1Seikagaku Corporation
- Adamts12 as a target molecule for the treatment of chronic renal insufficiency and renal fibrosis16 Jul 2026US 2026/0202408 A1Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen
- Method of preventing and/or reducing metastasis of tumor cells, preventing or reducing senescence, inhibiting differentiation and of reducing inflammation2 Jul 2026US 2026/0185980 A1Albert-Ludwigs-Universitaet
Most cited
By later US patents
- Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis58US 5,976,822 ACoulter International Corp. · 1999
- Method for determining activity of enzymes in metabolically active whole cells34US 5,698,411 ACoulter Corporation · 1997
- Identification of blast cells in a leukocyte cell preparation24US 5,905,031 ACoulter International Corp. · 1999
- Treatment of chronic pelvic pain syndrome15US 8,586,044 B2Northwestern University · 2013
- Clostridium histolyticum enzymes and methods for the use thereof15US 9,757,435 B2Endo Global Ventures · 2017